Skip to Main Content

Paper Details

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Blood
56
2022
4-1BB, B, B-ALL, B-cell acute lymphoblastic leukemia, B-cell malignancies, CAR, CAR T cells, CAR T-cell, CAYA B-ALL, CD19, CD19.22.BB, CD19/22, CD22, CD22.BB, CRS, EF1, MSCV, MSCV promoters, bicistronic CAR, bicistronic CD19, children, chimeric antigen receptor, chimeric antigen receptor (CAR) T-cells, cytokine, cytokine release syndrome, humanized, leukemia, mice, murine, murine stem cell virus (MSCV)-CD19/, neurotoxicity, patients
Author NameAffiliation
Angela Su
Seth M SteinbergCenter for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH)
Seth M SteinbergCenter for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH)
David F StroncekCenter for Cellular Engineering, NIH Clinical Center
David F StroncekCenter for Cellular Engineering, NIH Clinical Center
  • 1 - 5

Datasets

Release 1.2